Skip to main content

NDDC Probe: CSOs to Akpabio, publish names of NGOs as contract beneficiaries

NDDC Probe: CSOs to Akpabio, publish names of NGOs as contract beneficiaries

NDDC Probe: CSOs to Akpabio, publish names of NGOs as contract beneficiaries

By Gabriel Ewepu – Abuja

Niger Delta-based Nongovernmental Organisations, NGOs, Friday, challenged the Minister of Niger Delta Affairs, Sen God’swill Akpabio, to publish names of NGOs are contract beneficiaries of the Niger Delta Development Commission, NDDC, as claimed at the ongoing probe by the National Assembly Probe Committee.

The demand was made by the Executive Director, Africa Network for Environmental and Economic Justice, ANEEJ, Rev David Ugolor, on behalf of the NGOs while speaking on the claim made by the Minister at the hearing of the Committee.

It will be recalled that 37 CSOs in the region recently demanded that there should be a thorough investigation into factors that led to the level of reckless looting that has been associated with the Commission since its inception, and anybody found culpable should be prosecuted.

They also accused the Commission of bulk withdrawal allegedly made from the Commission’s account while its probe was ongoing at the National Assembly, and called for immediate freezing to withdrawals of the accounts of the Commission.

READ ALSO: EFCC, NDDC probes: Political appointees abusing trust – Buhari

Ugolor said: “We are challenging Akpabio and the acting Managing Director of NDDC to publish the names of NGOs that got jobs and did not carry it out or involved in dubious contract processes.

“As a matter of fact, all NGOs that have gotten jobs from NDDC let their names be published and details of the contracts they got in order for them to be scrutinized.”

He further stated that the Minister and MD should not think NGOs who are working in the Niger Delta region are corrupt and does not mean well for the people, and added that if it is to score a cheap political point and also to bring credible NGOs to disrepute without verifiable claims he (Akpabio) should show facts.

“They should not undermine and create creditability problems for NGOs working in the region selflessly to better the lives of the people including their environment”, he said.

He also added that “As civil society organizations and the people of the region, we have documented all the allegations of corruption and abuse of due process in the Commission revealed at the public hearing.”

Vanguard

The post NDDC Probe: CSOs to Akpabio, publish names of NGOs as contract beneficiaries appeared first on Vanguard News.


by Lawal Sherifat via Vanguard News https://ift.tt/2Xe3qUs Best Known Member of the Cabinet Wikipedia
Labels:

Comments

Post a Comment

Popular posts from this blog

Effective Data Governance: IIM-Africa inks partnership deal with Data Management University

President/Chairman of the governing council of IIM-Africa, Dr. Oyedokun Oyewole has said that effective data governance strategy has become more essential for the survival and sustenance of government and businesses, especially with the sudden outbreak of COVID-19 Pandemic. Oyewole said there is the need to ensure that the right policies, processes, technology, and people are in place to effectively manage data while complying with legal and regulatory requirements. He said that as part of the IIM Africa’s commitments towards ensuring global best practices, it has entered into a long-term partnership with DataManagementU.com to bring the finest data management training to industries across Africa. READ ALSO:  COVID-19: Foreign affairs minister says first set of Nigerians abroad to be evacuated soon According to the IIM President, the alliance is expected to provide members of the Institute and other professionals across Africa, high standards, internationally-recognized learn...
Post a Comment
Read more

Remdesivir: The COVID-19 drug helping patients recover faster

A vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. PHOTO: AP Remdesivir has been shown to speed up recovery times for patients with COVID-19 in a major US-led trial, becoming the first drug with proven benefit against the disease. Here is what you need to know. – What is remdesivir? – Remdesivir is an experimental, broad spectrum antiviral made by US pharmaceutical Gilead Sciences that was first developed to treat Ebola, a viral hemorrhagic fever. It showed early promise in a primate study in 2016 and was later rolled out for a major trial in the Democratic Republic of Congo, where it was compared against three other medicines. That study concluded in 2019 when it was discontinued because it did not boost survival rates as greatly as two monoclonal antibody drugs, which are lab-engineered immune system proteins. In February, the US National Institute of Allergy and Infectious Diseases (NIAID) announced ...
Post a Comment
Read more

Naomi Osaka’s statement about withdrawing from French Open

Japan’s Naomi Osaka returns the ball to Romania’s Patricia Maria Tig during their first round match of the French open tennis tournament at the Roland Garros stadium Sunday, May 30, 2021 in Paris. (AP Photo/Christophe Ena) Naomi Osaka tweeted the following statement announcing her withdrawal from the French Open on Monday: “Hey everyone, this isn’t a situation I ever imagined or intended when I posted a few days ago. I think now the best thing for the tournament, the other players and my well-being is that I withdraw so that everyone can get back to focusing on the tennis going on in Paris. ”I never wanted to be a distraction and I accept that my timing was not idea and my message could have been clearer. ”More importantly I would never trivialize mental health or use the term lightly. The truth is that I have suffered long bouts of depression since the US Open in 2018 and I have had a really hard time coping with that. Anyone that knows me knows I’m introverted, and anyone tha...
Post a Comment
Read more